| Literature DB >> 26273656 |
Norshalizah Mamikutty1, Zar Chi Thent2, Farihah Haji Suhaimi2.
Abstract
BACKGROUND: Nonalcoholic fatty liver disease (NAFLD) is one of the complications of the metabolic syndrome. It encompasses a wide range of disease spectrum from simple steatosis to liver cirrhosis. Structural alteration of hepatic mitochondria might be involved in the pathogenesis of NAFLD. AIMS: In the present study, we used a newly established model of fructose-induced metabolic syndrome in male Wistar rats in order to investigate the ultrastructural changes in hepatic mitochondria that occur with fructose consumption and their association with NAFLD pathogenesis.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26273656 PMCID: PMC4529952 DOI: 10.1155/2015/895961
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Effects of fructose-drinking water on metabolic variables in C and F20 groups for 8 weeks.
| Variables | C | F20 | ||
|---|---|---|---|---|
| Baseline | 8 weeks | Baseline | 8 weeks | |
| Body weight gain (%) | — | 36.12 ± 0.81 | — | 43.03 ± 0.76a |
| Body mass index (g/cm2) | 0.64 ± 0.01 | 0.66 ± 0.02 | 0.64 ± 0.02 | 0.91 ± 0.02ab |
| Abdominal circumference (cm) | 16.5 ± 0.26 | 18.3 ± 0.1 | 16.1 ± 0.40 | 22.9 ± 0.3ab |
| Total abdominal fat (mg/mm tibial length) | — | 196.72 ± 23.13 | — | 437.97 ± 27.08a |
| Plasma triglyceride (mmol/L) | 0.70 ± 0.09 | 0.65 ± 0.08 | 0.78 ± 0.07 | 1.22 ± 0.14ab |
| Plasma total cholesterol (mmol/L) | 1.5 ± 0.01 | 1.6 ± 0.1 | 1.5 ± 0.04 | 1.5 ± 0.1 |
| Systolic blood pressure (mmHg) | 103.3 ± 1.1 | 105.0 ± 1.8 | 101.3 ± 2.1 | 145.8 ± 1.5ab |
| Plasma glucose (mmol/L) | 5.1 ± 0.4 | 6.4 ± 0.2 | 4.7 ± 0.4 | 8.1 ± 0.6ab |
Values are mean ± SEM and n = 6 for each group. Superscripts letters are significantly different. aA significant difference as compared to C group at 8 weeks. bA significant difference within groups as compared to baseline.
Figure 1The bar graph of liver enzymes AST and ALT showed that there was no significant difference of the liver enzymes in between C and F20 at day 56 and there was no significant difference within each group at baseline and day 56.
Figure 2The bar graph of liver weight showed that there was no significant difference of the weight of the liver in between C and F20.
Figure 3Hematoxylin and eosin staining of liver showed depositions of lipid vacuoles (arrow) in hepatocyte cytoplasm of F20 (b). Special staining of lipid vacuoles by ORO stained the lipid vacuoles with red and the nucleus of hepatocyte with blue in the F20 (d). TEM of F20 (f) showed the distorted nucleus of hepatocyte and multiple lipid depositions in the cytoplasm. No deposition of lipid vacuoles seen in the C group. N-nucleus and LV-lipid vacuoles.
Figure 4The transmission electron micrograph of hepatocytes from C group (a) and F20 group (b) at magnification ×11 500. The F20 group developed hepatic steatosis. The mitochondria from F20 group were bigger in sizes with swollen, disrupted cristae and hypodense matrix. Mi-mitochondria and LV-lipid vacuole. The arrow shows the cristae.